WORLD CANCER DAY

Chronix Biomedical

World Cancer Day is a perfect opportunity to focus on your health state...

By | February 3rd, 2017|Chronix news|0 Comments

Blood test could identify aggressive prostate cancer

The Times

The Times: thousands of men with prostate cancer could be saved from unnecessary operations thanks to a blood test...

By | November 8th, 2016|Chronix news|0 Comments

Chronix Biomedical updates on progress with prostate and pancreatic cancer validation studies

Chronix Biomedical

Chronix Biomedical, Inc., a developer of novel cancer blood-based molecular diagnostics, is pleased to update investors on the progress of two clinical studies...

By | November 3rd, 2016|Chronix news|0 Comments

Cancer – what you need to know?

UK Cancer Research

UK Cancer Research has created Cancer Statistic: Early diagnosis of cancer increases the chances of a full recovery. That's why Advanced Cancer Diagnostics puts attention to the importance of cancer screening. Cancer can’t...

By | October 28th, 2016|Chronix news|0 Comments

Cancer Moonshot – Initiative of the Government of the United States

Chronix Biomedical

"The Cancer Moonshot Initiative’s mission of speeding cures for the hundreds of cancers we treat is much more complex than putting a man on the moon." President Barack Obama’s announcement of a Cancer Moonshot Initiative...

By | October 13th, 2016|Chronix news|0 Comments

20 Years Later: A Cancer DNA Load Blood Test

Chronix Biomedical

Chronix Biomedical filed its first patent application 20 years ago on October 4, 1996. This first patent application has subsequently led to a series of exciting developments culminating in revolutionary genetic testing technology to diagnose...

By | October 4th, 2016|Chronix news|0 Comments

#TheTurningPointInCancerFight

Chronix Biomedical

Exactly 20 years ago, on 4th of October 1996, Howard Urnovitz, founder and CEO of Chronix Biomedical, an innovative biomedical company from Palo Alto (California, US), has applied for a Patent, which was the result...

By | October 4th, 2016|Chronix news|0 Comments

Chronix Biomedical welcomes moves to define new regulatory standards in liquid biopsy field

Chronix Biomedical

San Jose, CA, USA and Göttingen, Germany (20 July 2016) – Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, welcomes the recent moves to more clearly define US regulatory standards for the use of...

By | July 20th, 2016|Chronix news|0 Comments

Chronix Biomedical’s serum DNA assays can monitor disease activity and treatment response in multiple sclerosis

Chronix Biomedical

San Jose, California, April 6, 2010 – Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to...

By | June 3rd, 2016|Chronix news|0 Comments

New study shows blood test detected cancer metastasis

Chronix Biomedical

RESEARCH BY CHRONIX BIOMEDICAL AND INSTITUTE OF VETERINARY MEDICINE GÖTTINGEN HIGHLIGHTS CELL-FREE DNA ANALYSIS FOR CANCER MINIMAL RESIDUAL DISEASE San Jose, CA and Göttingen, Germany—September 30, 2013—Researchers from the University Göttingen Institute of Veterinary Medicine...

By | June 1st, 2016|Chronix news|0 Comments